These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

405 related articles for article (PubMed ID: 29702489)

  • 1. What's new in short bowel syndrome?
    Billiauws L; Corcos O; Joly F
    Curr Opin Clin Nutr Metab Care; 2018 Jul; 21(4):313-318. PubMed ID: 29702489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential Effects on Intestinal Adaptation Following Exogenous Glucagon-Like Peptide 2 Therapy With and Without Enteral Nutrition in Neonatal Short Bowel Syndrome [Formula: see text].
    Lim DW; Diané A; Muto M; Vine DF; Nation PN; Wizzard PR; Sigalet DL; Bigam DL; Pencharz PB; Turner JM; Wales PW
    JPEN J Parenter Enteral Nutr; 2017 Feb; 41(2):156-170. PubMed ID: 27660290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential action of TGR5 agonists on GLP-2 secretion and promotion of intestinal adaptation in a piglet short bowel model.
    Lin S; Stoll B; Robinson J; Pastor JJ; Marini JC; Ipharraguerre IR; Hartmann B; Holst JJ; Cruz S; Lau P; Olutoye O; Fang Z; Burrin DG
    Am J Physiol Gastrointest Liver Physiol; 2019 May; 316(5):G641-G652. PubMed ID: 30920308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modern treatment of short bowel syndrome.
    Jeppesen PB
    Curr Opin Clin Nutr Metab Care; 2013 Sep; 16(5):582-7. PubMed ID: 23924950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exogenous glucagon-like peptide-2 improves outcomes of intestinal adaptation in a distal-intestinal resection neonatal piglet model of short bowel syndrome.
    Suri M; Turner JM; Sigalet DL; Wizzard PR; Nation PN; Ball RO; Pencharz PB; Brubaker PL; Wales PW
    Pediatr Res; 2014 Oct; 76(4):370-7. PubMed ID: 24995913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short Bowel Syndrome: A Paradigm for Intestinal Adaptation to Nutrition?
    Le Beyec J; Billiauws L; Bado A; Joly F; Le Gall M
    Annu Rev Nutr; 2020 Sep; 40():299-321. PubMed ID: 32631145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging treatments for short bowel syndrome in adult patients.
    Billiauws L; Joly F
    Expert Rev Gastroenterol Hepatol; 2019 Mar; 13(3):241-246. PubMed ID: 30791759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gut hormones, and short bowel syndrome: the enigmatic role of glucagon-like peptide-2 in the regulation of intestinal adaptation.
    Martin GR; Beck PL; Sigalet DL
    World J Gastroenterol; 2006 Jul; 12(26):4117-29. PubMed ID: 16830359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel effect of glucagon-like peptide-2 for hepatocellular injury in a parenterally fed rat model of short bowel syndrome.
    Yano K; Kaji T; Onishi S; Machigashira S; Nagai T; Harumatsu T; Yamada K; Yamada W; Muto M; Nakame K; Mukai M; Ieiri S
    Pediatr Surg Int; 2019 Dec; 35(12):1345-1351. PubMed ID: 31555865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Teduglutide for treatment of adult patients with short bowel syndrome.
    Billiauws L; Bataille J; Boehm V; Corcos O; Joly F
    Expert Opin Biol Ther; 2017 May; 17(5):623-632. PubMed ID: 28293969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucagon-Like Peptide 2 Stimulates Postresection Intestinal Adaptation in Preterm Pigs by Affecting Proteins Related to Protein, Carbohydrate, and Sulphur Metabolism.
    Jiang P; Vegge A; Thymann T; Wan JM; Sangild PT
    JPEN J Parenter Enteral Nutr; 2017 Nov; 41(8):1293-1300. PubMed ID: 27503937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucagon-like peptide-2 induces rapid digestive adaptation following intestinal resection in preterm neonates.
    Vegge A; Thymann T; Lund P; Stoll B; Bering SB; Hartmann B; Jelsing J; Qvist N; Burrin DG; Jeppesen PB; Holst JJ; Sangild PT
    Am J Physiol Gastrointest Liver Physiol; 2013 Aug; 305(4):G277-85. PubMed ID: 23764891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergy of glucagon-like peptide-2 and epidermal growth factor coadministration on intestinal adaptation in neonatal piglets with short bowel syndrome.
    Lim DW; Levesque CL; Vine DF; Muto M; Koepke JR; Nation PN; Wizzard PR; Li J; Bigam DL; Brubaker PL; Turner JM; Wales PW
    Am J Physiol Gastrointest Liver Physiol; 2017 Apr; 312(4):G390-G404. PubMed ID: 28104586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of exogenous glucagon-like peptide-2 and distal bowel resection on intestinal and systemic adaptive responses in rats.
    Lai SW; de Heuvel E; Wallace LE; Hartmann B; Holst JJ; Brindle ME; Chelikani PK; Sigalet DL
    PLoS One; 2017; 12(7):e0181453. PubMed ID: 28738080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medical and surgical management of short bowel syndrome.
    Billiauws L; Maggiori L; Joly F; Panis Y
    J Visc Surg; 2018 Sep; 155(4):283-291. PubMed ID: 30041905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short bowel syndrome: highlights of patient management, quality of life, and survival.
    Kelly DG; Tappenden KA; Winkler MF
    JPEN J Parenter Enteral Nutr; 2014 May; 38(4):427-37. PubMed ID: 24247092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enterohormone therapy for short bowel syndrome.
    Verbiest A; Wauters L; Vanuytsel T
    Curr Opin Endocrinol Diabetes Obes; 2022 Apr; 29(2):207-218. PubMed ID: 35034035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic potential of an intestinotrophic hormone, glucagon-like peptide 2, for treatment of type 2 short bowel syndrome rats with intestinal bacterial and fungal dysbiosis.
    Hu X; Cheng W; Fan S; Huang Y; Chen X; Jiang Z; Wang J
    BMC Infect Dis; 2021 Jun; 21(1):583. PubMed ID: 34134659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute effects of continuous infusions of glucagon-like peptide (GLP)-1, GLP-2 and the combination (GLP-1+GLP-2) on intestinal absorption in short bowel syndrome (SBS) patients. A placebo-controlled study.
    Madsen KB; Askov-Hansen C; Naimi RM; Brandt CF; Hartmann B; Holst JJ; Mortensen PB; Jeppesen PB
    Regul Pept; 2013 Jun; 184():30-9. PubMed ID: 23511332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality of life in patients with short bowel syndrome treated with the new glucagon-like peptide-2 analogue teduglutide--analyses from a randomised, placebo-controlled study.
    Jeppesen PB; Pertkiewicz M; Forbes A; Pironi L; Gabe SM; Joly F; Messing B; Loth S; Youssef NN; Heinze H; Berghöfer P
    Clin Nutr; 2013 Oct; 32(5):713-21. PubMed ID: 23587733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.